{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T01:21:55Z","timestamp":1785892915880,"version":"3.56.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,7]],"date-time":"2019-10-07T00:00:00Z","timestamp":1570406400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,10,7]],"date-time":"2019-10-07T00:00:00Z","timestamp":1570406400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004484","name":"Tehran University of Medical Sciences","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004484","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Finding new biomarkers for the early detection of cervical cancer is an essential requirement in this field. In this study, we aimed to evaluate the expression level of potential biomarkers in progression of cervical cancer in patients with cervical cancer compared to normal subjects.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The expression levels of tissue and serum miRNAs, including miR-9, miR-192 and miR-205, were investigated in 36 normal, 18 precancer, and 18 cervical cancer samples using real-time polymerase chain reaction.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The results showed the higher significant expressions of miR-9, miR-192 and miR-205 in the tissue of cancer samples than those in the normal samples. Moreover, the miR-192 and miR-205 expression were significantly increased in the cancer group in comparison with the precancer group. Examination of serum samples revealed the increase in the expression level in the cancer groups than in the normal samples, for miR-9, miR-192 and miR-205 and the expressions of miR-9, miR-192 and miR-205 were significantly up-regulated in the precancer group in comparison with the normal group. Also the expression of miR-205 was remarkably increased in the cancer group in comparison with the precancer group. The receiver operating characteristic (ROC) analyses showed the highest area under the curve value for miR-192.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Given the increased expression level of miR-192 in cancer and in precancerous tissue and serum compared with the normal tissue and serum validated by analysing the ROC curve, miR-192 can be used as potential biomarker for the early detection of cervical cancer.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12985-019-1220-y","type":"journal-article","created":{"date-parts":[[2019,10,7]],"date-time":"2019-10-07T13:19:37Z","timestamp":1570454377000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Serum and tissue miRNAs: potential biomarkers for the diagnosis of cervical cancer"],"prefix":"10.1186","volume":"16","author":[{"given":"Mahdieh","family":"Farzanehpour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayed-Hamidreza","family":"Mozhgani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somayeh","family":"Jalilvand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebrahim","family":"Faghihloo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Setareh","family":"Akhavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vahid","family":"Salimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talat Mokhtari","family":"Azad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,7]]},"reference":[{"key":"1220_CR1","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.2147\/IJWH.S49471","volume":"6","author":"A Duenas-Gonzalez","year":"2014","unstructured":"Duenas-Gonzalez A, Serrano-Olvera A, Cetina L, Coronel J. New molecular targets against cervical cancer. Int J Women\u2019s Health. 2014;6:1023\u201331.","journal-title":"Int J Women\u2019s Health"},{"key":"1220_CR2","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/S1470-2045(12)70211-5","volume":"13","author":"F Bray","year":"2012","unstructured":"Bray F, Jemal A, Grey N, Ferlay J, Forman D. Global cancer transitions according to the human development index (2008-2030): a population-based study. Lancet Oncol. 2012;13:790\u2013801.","journal-title":"Lancet Oncol"},{"key":"1220_CR3","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/nrc2886","volume":"10","author":"CA Moody","year":"2010","unstructured":"Moody CA, Laimins LA. Human papillomavirus oncoproteins: pathways to transformation. Nat Rev Cancer. 2010;10:550\u201360.","journal-title":"Nat Rev Cancer"},{"issue":"Suppl 5","key":"1220_CR4","doi-asserted-by":"publisher","first-page":"F55","DOI":"10.1016\/j.vaccine.2012.06.083","volume":"30","author":"J Doorbar","year":"2012","unstructured":"Doorbar J, Quint W, Banks L, Bravo IG, Stoler M, Broker TR, Stanley MA. The biology and life-cycle of human papillomaviruses. Vaccine. 2012;30(Suppl 5):F55\u201370.","journal-title":"Vaccine"},{"issue":"5","key":"1220_CR5","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/nrc798","volume":"2","author":"Harald zur Hausen","year":"2002","unstructured":"zur Hausen H: Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2002, 2:342\u2013350.","journal-title":"Nature Reviews Cancer"},{"key":"1220_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0001574","volume":"3","author":"T Geiger","year":"2008","unstructured":"Geiger T, Sabanay H, Kravchenko-Balasha N, Geiger B, Levitzki A. Anomalous features of EMT during keratinocyte transformation. PLoS One. 2008;3:e1574.","journal-title":"PLoS One"},{"key":"1220_CR7","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/nrc822","volume":"2","author":"JP Thiery","year":"2002","unstructured":"Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer. 2002;2:442\u201354.","journal-title":"Nat Rev Cancer"},{"key":"1220_CR8","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/nature07228","volume":"455","author":"M Selbach","year":"2008","unstructured":"Selbach M, Schwanhausser B, Thierfelder N, Fang Z, Khanin R, Rajewsky N. Widespread changes in protein synthesis induced by microRNAs. Nature. 2008;455:58\u201363.","journal-title":"Nature"},{"key":"1220_CR9","first-page":"668","volume":"2011","author":"ZM Zheng","year":"1809","unstructured":"Zheng ZM, Wang X. Regulation of cellular miRNA expression by human papillomaviruses. Biochim Biophys Acta. 1809;2011:668\u201377.","journal-title":"Biochim Biophys Acta"},{"key":"1220_CR10","doi-asserted-by":"publisher","first-page":"9628","DOI":"10.1158\/0008-5472.CAN-05-2352","volume":"65","author":"Y Hayashita","year":"2005","unstructured":"Hayashita Y, Osada H, Tatematsu Y, Yamada H, Yanagisawa K, Tomida S, Yatabe Y, Kawahara K, Sekido Y, Takahashi T. A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res. 2005;65:9628\u201332.","journal-title":"Cancer Res"},{"key":"1220_CR11","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1038\/nature03552","volume":"435","author":"L He","year":"2005","unstructured":"He L, Thomson JM, Hemann MT, Hernando-Monge E, Mu D, Goodson S, Powers S, Cordon-Cardo C, Lowe SW, Hannon GJ, Hammond SM. A microRNA polycistron as a potential human oncogene. Nature. 2005;435:828\u201333.","journal-title":"Nature"},{"issue":"7043","key":"1220_CR12","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/nature03677","volume":"435","author":"Kathryn A. O'Donnell","year":"2005","unstructured":"O'Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT: c-Myc-regulated microRNAs modulate E2F1 expression. Nature 2005, 435:839\u2013843.","journal-title":"Nature"},{"key":"1220_CR13","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.gde.2005.12.005","volume":"16","author":"SM Hammond","year":"2006","unstructured":"Hammond SM. MicroRNAs as oncogenes. Curr Opin Genet Dev. 2006;16:4\u20139.","journal-title":"Curr Opin Genet Dev"},{"key":"1220_CR14","doi-asserted-by":"publisher","first-page":"461","DOI":"10.2174\/092986712798918798","volume":"19","author":"G Fiorucci","year":"2012","unstructured":"Fiorucci G, Chiantore MV, Mangino G, Percario ZA, Affabris E, Romeo G. Cancer regulator microRNA: potential relevance in diagnosis, prognosis and treatment of cancer. Curr Med Chem. 2012;19:461\u201374.","journal-title":"Curr Med Chem"},{"key":"1220_CR15","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.canlet.2009.04.031","volume":"285","author":"K Ruan","year":"2009","unstructured":"Ruan K, Fang X, Ouyang G. MicroRNAs: novel regulators in the hallmarks of human cancer. Cancer Lett. 2009;285:116\u201326.","journal-title":"Cancer Lett"},{"key":"1220_CR16","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/ncb0310-209","volume":"12","author":"Y Khew-Goodall","year":"2010","unstructured":"Khew-Goodall Y, Goodall GJ. Myc-modulated miR-9 makes more metastases. Nat Cell Biol. 2010;12:209\u201311.","journal-title":"Nat Cell Biol"},{"key":"1220_CR17","doi-asserted-by":"publisher","first-page":"6416","DOI":"10.1158\/1078-0432.CCR-12-0832","volume":"18","author":"MH Lu","year":"2012","unstructured":"Lu MH, Huang CC, Pan MR, Chen HH, Hung WC. Prospero homeobox 1 promotes epithelial-mesenchymal transition in colon cancer cells by inhibiting E-cadherin via miR-9. Clin Cancer Res. 2012;18:6416\u201325.","journal-title":"Clin Cancer Res"},{"key":"1220_CR18","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/ncb2024","volume":"12","author":"L Ma","year":"2010","unstructured":"Ma L, Young J, Prabhala H, Pan E, Mestdagh P, Muth D, Teruya-Feldstein J, Reinhardt F, Onder TT, Valastyan S, et al. miR-9, a MYC\/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat Cell Biol. 2010;12:247\u201356.","journal-title":"Nat Cell Biol"},{"key":"1220_CR19","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/j.molonc.2013.04.007","volume":"7","author":"Z Sun","year":"2013","unstructured":"Sun Z, Han Q, Zhou N, Wang S, Lu S, Bai C, Zhao RC. MicroRNA-9 enhances migration and invasion through KLF17 in hepatocellular carcinoma. Mol Oncol. 2013;7:884\u201394.","journal-title":"Mol Oncol"},{"key":"1220_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0078713","volume":"8","author":"G Feinberg-Gorenshtein","year":"2013","unstructured":"Feinberg-Gorenshtein G, Guedj A, Shichrur K, Jeison M, Luria D, Kodman Y, Ash S, Feinmesser M, Edry L, Shomron N, et al. MiR-192 directly binds and regulates Dicer1 expression in neuroblastoma. PLoS One. 2013;8:e78713.","journal-title":"PLoS One"},{"key":"1220_CR21","doi-asserted-by":"publisher","first-page":"276","DOI":"10.3892\/or.2013.2420","volume":"30","author":"C Zhao","year":"2013","unstructured":"Zhao C, Zhang J, Zhang S, Yu D, Chen Y, Liu Q, Shi M, Ni C, Zhu M. Diagnostic and biological significance of microRNA-192 in pancreatic ductal adenocarcinoma. Oncol Rep. 2013;30:276\u201384.","journal-title":"Oncol Rep"},{"key":"1220_CR22","doi-asserted-by":"publisher","first-page":"560","DOI":"10.3892\/etm.2011.436","volume":"3","author":"Y Chiang","year":"2012","unstructured":"Chiang Y, Song Y, Wang Z, Liu Z, Gao P, Liang J, Zhu J, Xing C, Xu H. microRNA-192, \u2212194 and \u2212215 are frequently downregulated in colorectal cancer. Exp Ther Med. 2012;3:560\u20136.","journal-title":"Exp Ther Med"},{"key":"1220_CR23","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.clcc.2011.06.002","volume":"10","author":"M Karaayvaz","year":"2011","unstructured":"Karaayvaz M, Pal T, Song B, Zhang C, Georgakopoulos P, Mehmood S, Burke S, Shroyer K, Ju J. Prognostic significance of miR-215 in colon cancer. Clin Colorectal Cancer. 2011;10:340\u20137.","journal-title":"Clin Colorectal Cancer"},{"key":"1220_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0107986","volume":"9","author":"Y Tan","year":"2014","unstructured":"Tan Y, Ge G, Pan T, Wen D, Chen L, Yu X, Zhou X, Gan J. A serum microRNA panel as potential biomarkers for hepatocellular carcinoma related with hepatitis B virus. PLoS One. 2014;9:e107986.","journal-title":"PLoS One"},{"key":"1220_CR25","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1042\/CS20100297","volume":"120","author":"J Gui","year":"2011","unstructured":"Gui J, Tian Y, Wen X, Zhang W, Zhang P, Gao J, Run W, Tian L, Jia X, Gao Y. Serum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologies. Clin Sci (Lond). 2011;120:183\u201393.","journal-title":"Clin Sci (Lond)"},{"key":"1220_CR26","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.3892\/or.2014.3004","volume":"31","author":"Q Chen","year":"2014","unstructured":"Chen Q, Ge X, Zhang Y, Xia H, Yuan D, Tang Q, Chen L, Pang X, Leng W, Bi F. Plasma miR-122 and miR-192 as potential novel biomarkers for the early detection of distant metastasis of gastric cancer. Oncol Rep. 2014;31:1863\u201370.","journal-title":"Oncol Rep"},{"key":"1220_CR27","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.ejcb.2012.11.002","volume":"92","author":"AY Qin","year":"2013","unstructured":"Qin AY, Zhang XW, Liu L, Yu JP, Li H, Wang SZ, Ren XB, Cao S. MiR-205 in cancer: an angel or a devil? Eur J Cell Biol. 2013;92:54\u201360.","journal-title":"Eur J Cell Biol"},{"key":"1220_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0046990","volume":"7","author":"H Xie","year":"2012","unstructured":"Xie H, Zhao Y, Caramuta S, Larsson C, Lui WO. miR-205 expression promotes cell proliferation and migration of human cervical cancer cells. PLoS One. 2012;7:e46990.","journal-title":"PLoS One"},{"key":"1220_CR29","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.1200\/JCO.2008.19.4134","volume":"27","author":"D Lebanony","year":"2009","unstructured":"Lebanony D, Benjamin H, Gilad S, Ezagouri M, Dov A, Ashkenazi K, Gefen N, Izraeli S, Rechavi G, Pass H, et al. Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma. J Clin Oncol. 2009;27:2030\u20137.","journal-title":"J Clin Oncol"},{"key":"1220_CR30","volume-title":"Cervical intraepithelial neoplasia (CIN) in African women living with HIV: role and effect of rigorous histopathological review by a panel of pathologists in the HARP study endpoint determination","author":"S Doutre","year":"2017","unstructured":"Doutre S, Omar T, Goumbri-Lompo O, Kelly H, Clavero O, Zan S, Chikandiwa A, Sawadogo B, Delany-Moretlwe S, Costes V, et al: Cervical intraepithelial neoplasia (CIN) in African women living with HIV: role and effect of rigorous histopathological review by a panel of pathologists in the HARP study endpoint determination. 2017."},{"key":"1220_CR31","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1007\/s00705-016-3213-0","volume":"162","author":"M Jafarian","year":"2017","unstructured":"Jafarian M, Mozhgani SH, Patrad E, Vaziri H, Rezaee SA, Akbarin MM, Norouzi M. Evaluation of INOS, ICAM-1, and VCAM-1 gene expression: a study of adult T cell leukemia malignancy associated with HTLV-1. Arch Virol. 2017;162:1009\u201315.","journal-title":"Arch Virol"},{"key":"1220_CR32","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.ygyno.2015.06.015","volume":"138","author":"Y Yang","year":"2015","unstructured":"Yang Y, Xie YJ, Xu Q, Chen JX, Shan NC, Zhang Y. Down-regulation of miR-1246 in cervical cancer tissues and its clinical significance. Gynecol Oncol. 2015;138:683\u20138.","journal-title":"Gynecol Oncol"},{"key":"1220_CR33","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.5858\/2003-127-1471-HPIOTE","volume":"127","author":"A Svec","year":"2003","unstructured":"Svec A, Mikyskova I, Hes O, Tachezy R. Human papillomavirus infection of the epididymis and ductus deferens: an evaluation by nested polymerase chain reaction. Arch Pathol Lab Med. 2003;127:1471\u20134.","journal-title":"Arch Pathol Lab Med"},{"key":"1220_CR34","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1007\/s00384-014-1930-y","volume":"29","author":"MS Reimers","year":"2014","unstructured":"Reimers MS, Zeestraten EC, van Alphen TC, Dekker JW, Putter H, Saadatmand S, Liefers GJ, van de Velde CJ, Kuppen PJ. Combined analysis of biomarkers of proliferation and apoptosis in colon cancer: an immunohistochemistry-based study using tissue microarray. Int J Color Dis. 2014;29:1043\u201352.","journal-title":"Int J Color Dis"},{"key":"1220_CR35","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/nrg2290","volume":"9","author":"W Filipowicz","year":"2008","unstructured":"Filipowicz W, Bhattacharyya SN, Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet. 2008;9:102\u201314.","journal-title":"Nat Rev Genet"},{"key":"1220_CR36","doi-asserted-by":"publisher","first-page":"5692","DOI":"10.1093\/nar\/gkr148","volume":"39","author":"MP Gantier","year":"2011","unstructured":"Gantier MP, McCoy CE, Rusinova I, Saulep D, Wang D, Xu D, Irving AT, Behlke MA, Hertzog PJ, Mackay F, Williams BR. Analysis of microRNA turnover in mammalian cells following Dicer1 ablation. Nucleic Acids Res. 2011;39:5692\u2013703.","journal-title":"Nucleic Acids Res"},{"key":"1220_CR37","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1038\/cr.2008.282","volume":"18","author":"X Chen","year":"2008","unstructured":"Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, Guo J, Zhang Y, Chen J, Guo X, et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 2008;18:997\u20131006.","journal-title":"Cell Res"},{"key":"1220_CR38","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/1472-6750-7-36","volume":"7","author":"J Li","year":"2007","unstructured":"Li J, Smyth P, Flavin R, Cahill S, Denning K, Aherne S, Guenther SM, O'Leary JJ, Sheils O. Comparison of miRNA expression patterns using total RNA extracted from matched samples of formalin-fixed paraffin-embedded (FFPE) cells and snap frozen cells. BMC Biotechnol. 2007;7:36.","journal-title":"BMC Biotechnol"},{"key":"1220_CR39","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1158\/1078-0432.CCR-07-1231","volume":"14","author":"JW Lee","year":"2008","unstructured":"Lee JW, Choi CH, Choi JJ, Park YA, Kim SJ, Hwang SY, Kim WY, Kim TJ, Lee JH, Kim BG, Bae DS. Altered MicroRNA expression in cervical carcinomas. Clin Cancer Res. 2008;14:2535\u201342.","journal-title":"Clin Cancer Res"},{"key":"1220_CR40","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s12957-017-1201-9","volume":"15","author":"HB Shi","year":"2017","unstructured":"Shi HB, Yu JX, Yu JX, Feng Z, Zhang C, Li GY, Zhao RN, Yang XB. Diagnostic significance of microRNAs as novel biomarkers for bladder cancer: a meta-analysis of ten articles. World J Surg Oncol. 2017;15:147.","journal-title":"World J Surg Oncol"},{"key":"1220_CR41","doi-asserted-by":"crossref","first-page":"11620","DOI":"10.18632\/oncotarget.2599","volume":"5","author":"W Liu","year":"2014","unstructured":"Liu W, Gao G, Hu X, Wang Y, Schwarz JK, Chen JJ, Grigsby PW, Wang X. Activation of miR-9 by human papillomavirus in cervical cancer. Oncotarget. 2014;5:11620.","journal-title":"Oncotarget"},{"key":"1220_CR42","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.canlet.2010.10.013","volume":"305","author":"N Korzeniewski","year":"2011","unstructured":"Korzeniewski N, Spardy N, Duensing A, Duensing S. Genomic instability and cancer: lessons learned from human papillomaviruses. Cancer Lett. 2011;305:113\u201322.","journal-title":"Cancer Lett"},{"key":"1220_CR43","doi-asserted-by":"publisher","first-page":"21414","DOI":"10.3390\/ijms141121414","volume":"14","author":"C Kalogirou","year":"2013","unstructured":"Kalogirou C, Spahn M, Krebs M, Joniau S, Lerut E, Burger M, Scholz CJ, Kneitz S, Riedmiller H, Kneitz B. MiR-205 is progressively down-regulated in lymph node metastasis but fails as a prognostic biomarker in high-risk prostate cancer. Int J Mol Sci. 2013;14:21414\u201334.","journal-title":"Int J Mol Sci"},{"key":"1220_CR44","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/978-1-62703-453-1_10","volume":"1024","author":"L Moldovan","year":"2013","unstructured":"Moldovan L, Batte K, Wang Y, Wisler J, Piper M. Analyzing the circulating microRNAs in exosomes\/extracellular vesicles from serum or plasma by qRT-PCR. Methods Mol Biol. 2013;1024:129\u201345.","journal-title":"Methods Mol Biol"},{"key":"1220_CR45","doi-asserted-by":"publisher","first-page":"4033","DOI":"10.7314\/APJCP.2014.15.9.4033","volume":"15","author":"AV Orang","year":"2014","unstructured":"Orang AV, Safaralizadeh R, Hosseinpour Feizi MA, Somi MH. Diagnostic and prognostic value of miR-205 in colorectal cancer. Asian Pac J Cancer Prev. 2014;15:4033\u20137.","journal-title":"Asian Pac J Cancer Prev"},{"key":"1220_CR46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0077853","volume":"8","author":"H Zheng","year":"2013","unstructured":"Zheng H, Zhang L, Zhao Y, Yang D, Song F, Wen Y, Hao Q, Hu Z, Zhang W, Chen K. Plasma miRNAs as diagnostic and prognostic biomarkers for ovarian cancer. PLoS One. 2013;8:e77853.","journal-title":"PLoS One"},{"key":"1220_CR47","doi-asserted-by":"publisher","first-page":"5332","DOI":"10.1038\/onc.2013.478","volume":"33","author":"L Geng","year":"2014","unstructured":"Geng L, Chaudhuri A, Talmon G, Wisecarver JL, Are C, Brattain M, Wang J. MicroRNA-192 suppresses liver metastasis of colon cancer. Oncogene. 2014;33:5332.","journal-title":"Oncogene"},{"key":"1220_CR48","doi-asserted-by":"crossref","unstructured":"Wu SY, Rupaimoole R, Shen F, Pradeep S, Pecot CV, Ivan C, Nagaraja AS, Gharpure KM, Pham E, Hatakeyama H. A miR-192-EGR1-HOXB9 regulatory network controls the angiogenic switch in cancer. Nat Commun. 2016;7.","DOI":"10.1038\/ncomms11169"},{"key":"1220_CR49","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.clgc.2012.01.001","volume":"10","author":"G Wang","year":"2012","unstructured":"Wang G, Chan ES-Y, Kwan BC-H, Li PK-T, Yip SK-H, Szeto C-C, Ng C-F. Expression of microRNAs in the urine of patients with bladder cancer. Clinical genitourinary cancer. 2012;10:106\u201313.","journal-title":"Clinical genitourinary cancer"},{"key":"1220_CR50","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.3892\/or.2014.3004","volume":"31","author":"Q Chen","year":"2014","unstructured":"Chen Q, Ge X, Zhang Y, Xia H, Yuan D, Tang Q, Chen L, Pang X, Leng W, Bi F. Plasma miR-122 and miR-192 as potential novel biomarkers for the early detection of distant metastasis of gastric cancer. Oncol Rep. 2014;31:1863\u201370.","journal-title":"Oncol Rep"},{"key":"1220_CR51","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","volume":"136","author":"DP Bartel","year":"2009","unstructured":"Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136:215\u201333.","journal-title":"Cell"},{"key":"1220_CR52","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1007\/s12032-009-9264-2","volume":"27","author":"HX Tan","year":"2010","unstructured":"Tan HX, Wang Q, Chen LZ, Huang XH, Chen JS, Fu XH, Cao LQ, Chen XL, Li W, Zhang LJ. MicroRNA-9 reduces cell invasion and E-cadherin secretion in SK-Hep-1 cell. Med Oncol. 2010;27:654\u201360.","journal-title":"Med Oncol"},{"key":"1220_CR53","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.2337\/db09-1736","volume":"59","author":"B Wang","year":"2010","unstructured":"Wang B, Herman-Edelstein M, Koh P, Burns W, Jandeleit-Dahm K, Watson A, Saleem M, Goodall GJ, Twigg SM, Cooper ME, Kantharidis P. E-cadherin expression is regulated by miR-192\/215 by a mechanism that is independent of the profibrotic effects of transforming growth factor-beta. Diabetes. 2010;59:1794\u2013802.","journal-title":"Diabetes"},{"key":"1220_CR54","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1007\/s10552-013-0162-8","volume":"24","author":"E-Q Wu","year":"2013","unstructured":"Wu E-Q, Liu B, Cui J-F, Chen W, Wang J-B, Lu L, Niyazi M, Zhao C, Ren S-D, Li C-Q. Prevalence of type-specific human papillomavirus and pap results in Chinese women: a multi-center, population-based cross-sectional study. Cancer Causes Control. 2013;24:795\u2013803.","journal-title":"Cancer Causes Control"},{"key":"1220_CR55","first-page":"1351","volume":"36","author":"Y Zhao","year":"2015","unstructured":"Zhao Y, Zhao F, Hu S, Chen W, Chen F, Cui J, Liu B, Zhang W, Zhang X, Pan Q. Multi-center cross-sectional study on type-specific human papillomavirus infection among Chinese women. Zhonghua liu xing bing xue za zhi=. Zhonghua liuxingbingxue zazhi. 2015;36:1351\u20136.","journal-title":"Zhonghua liuxingbingxue zazhi"},{"key":"1220_CR56","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ygyno.2010.03.007","volume":"118","author":"KD Sjoeborg","year":"2010","unstructured":"Sjoeborg KD, Trop\u00e9 A, Lie AK, Jonassen CM, Steinbakk M, Hansen M, Jacobsen MB, Cuschieri K, Eskild A. HPV genotype distribution according to severity of cervical neoplasia. Gynecol Oncol. 2010;118:29\u201334.","journal-title":"Gynecol Oncol"},{"key":"1220_CR57","first-page":"108","volume":"36","author":"PR Giorgi","year":"2012","unstructured":"Giorgi PR, Chini F, Borgia P, Guasticchi G, Carozzi FM, Confortini M, Angeloni C, Buzzoni C, Buonaguro FM. Human papilloma virus (HPV), cervical cancer incidence and screening uptake: differences among northern, central and southern Italy. Epidemiol Prev. 2012;36:108\u201319.","journal-title":"Epidemiol Prev"},{"key":"1220_CR58","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12985-018-1003-x","volume":"15","author":"W Long","year":"2018","unstructured":"Long W, Yang Z, Li X, Chen M, Liu J, Zhang Y, Sun X. HPV-16, HPV-58, and HPV-33 are the most carcinogenic HPV genotypes in southwestern China and their viral loads are associated with severity of premalignant lesions in the cervix. Virol J. 2018;15:94.","journal-title":"Virol J"},{"key":"1220_CR59","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1007\/s12032-011-9830-2","volume":"29","author":"Q Rao","year":"2012","unstructured":"Rao Q, Shen Q, Zhou H, Peng Y, Li J, Lin Z. Aberrant microRNA expression in human cervical carcinomas. Med Oncol. 2012;29:1242\u20138.","journal-title":"Med Oncol"},{"key":"1220_CR60","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1007\/s11033-013-2998-0","volume":"41","author":"J Ribeiro","year":"2014","unstructured":"Ribeiro J, Sousa H. MicroRNAs as biomarkers of cervical cancer development: a literature review on miR-125b and miR-34a. Mol Biol Rep. 2014;41:1525\u201331.","journal-title":"Mol Biol Rep"},{"key":"1220_CR61","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1111\/IGC.0b013e3181d63170","volume":"20","author":"B Li","year":"2010","unstructured":"Li B, Hu Y, Ye F, Li Y, Lv W, Xie X. Reduced miR-34a expression in normal cervical tissues and cervical lesions with high-risk human papillomavirus infection. Int J Gynecol Cancer. 2010;20:597\u2013604.","journal-title":"Int J Gynecol Cancer"},{"key":"1220_CR62","doi-asserted-by":"crossref","unstructured":"Pardini B, De Maria D, Francavilla A, Di Gaetano C, Ronco G, Naccarati A: MicroRNAs as markers of progression in cervical cancer: a systematic review 2018, 18:696.","DOI":"10.1186\/s12885-018-4590-4"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-019-1220-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12985-019-1220-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-019-1220-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T04:15:54Z","timestamp":1664597754000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-019-1220-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,7]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1220"],"URL":"https:\/\/doi.org\/10.1186\/s12985-019-1220-y","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,7]]},"assertion":[{"value":"2 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Ethics Committee of Biomedical Research at TUMS.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that there is no competing interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"116"}}